Abstract
Survival post-treatment for childhood malignancy is now in excess of 70%. Hence female reproductive potential following treatment must be addressed. Issues concerning subsequent uterine and ovarian function, fertility options and importantly the ethics and safety of treatment approaches are discussed herein.
MeSH terms
-
Cryopreservation / ethics
-
Cryopreservation / methods
-
Ethics, Clinical
-
Female
-
Humans
-
Infertility, Female / etiology*
-
Infertility, Female / prevention & control
-
Neoplasms / therapy*
-
Reproductive Techniques / ethics
-
Survivors
-
Uterine Diseases / etiology*
-
Uterine Diseases / prevention & control
-
Uterus / growth & development